FDA Clears Point-of-Care Vaginitis PCR Panel with CLIA Waiver
The 20-minute multiplex test delivers eight results covering bacterial vaginosis, Candida species, and trichomoniasis from clinician- or self-collected swabs.
Latest Articles
Editor's Top Picks
CMS Releases Preliminary 2027 CLFS Rates as CAP Calls for Payment Reform
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Guardant Health to Highlight Advances in Liquid Biopsy for Cancer Monitoring at ESMO 2026
Guardant Health will present 25 abstracts at ESMO 2026, highlighting new data on ctDNA liquid biopsy for cancer monitoring, including MRD surveillance and therapy resistance in lung, colorectal, and gastric cancers.New research examines how circulating tumor DNA testing could help detect cancer recurrence, track treatment response, and identify resistance across multiple cancer types.
Equipment & Supply Spotlight
Clinisys Adds Document Intelligence to Laboratory Information Platform
Clinisys has integrated document intelligence into its Laboratory Solution platform, enabling labs to convert unstructured documents into searchable, governed data for improved workflow efficiency and reduced manual entry.
News, Know-How & Standards
Disease Detection & Understanding
Diadem Secures US Patent for Blood-Based Alzheimer’s Disease Biomarker Detection
The patent expands intellectual property coverage for the blood-based assay ahead of its planned commercial launch.
